Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB26FDR37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,184
Award facts
- Contract value 100% obligated
- $13,184.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a ceiling value of $13,184.25. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 17, 2025, and represents a pharmaceutical supply transaction typical of DLA's medical procurement operations. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated capability to fulfill federal medical supply requirements through competitive award processes, with an extensive contract portfolio covering diverse pharmaceutical products across multiple therapeutic domains. This delivery order for Trelegy Ellipta, a combination maintenance inhaler for chronic obstructive pulmonary disease, reflects the company's ongoing role in supplying specialized medications to support Defense Health Agency operations and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB26FDR37?
SPE2DB26FDR37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FDR37 worth?
The government has obligated $13,184 on SPE2DB26FDR37.
Is contract SPE2DB26FDR37 an order under another contract?
Yes. SPE2DB26FDR37 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDR37 competed?
The extent of competition for SPE2DB26FDR37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award